Immunopharmacology and Immunotoxicology

eISSN: 1532-2513pISSN: 0892-3973

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Aims and Scope

Immunopharmacology and Immunotoxicology is a bimonthly peer-reviewed medical journal that covers preclinical and clinical studies on the regulatory effects of various agents on immunocompetent cells, as well as the immunotoxicity exerted by xenobiotics and drugs. Hence, the journal encompasses a broad range of pathologies (e.g. acute and chronic infections, allergy, autoimmunity, cancer, degenerative disorders, inflammation, and primary and secondary immunodeficiencies). It is published by Informa. Less

Key Metrics

CiteScore
4.7
Impact Factor
< 5
SJR
Q3Immunology
SNIP
0.83
8
Time to Publish
time-to-publish View Chart
9  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science
  • Scopus
  • SJR
Overview
  • Publisher
    TAYLOR & FRANCIS LTD
  • Language
    English
  • Frequency
    Quarterly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

check-iconMeets Top Publisher Standards: Essential for leading journals like Elsevier.
check-iconEnhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
check-iconTailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn morethumb-icon 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 8%
4-6 22%
7-9 23%
>9 47%

Topics Covered

Lipopolysaccharide
Flow cytometry
Oxidative stress
Anti-inflammatory
Sepsis
Quercetin
Ulcerative colitis
Experimental autoimmune encephalomyelitis
Prostate cancer
Reactive oxygen species
Gene expression
Osteoarthritis
Glutathione
Fluticasone
Thymic stromal lymphopoietin
Cytokine storm
Nitric oxide
Glycerol
Acute failure
Liver injury

Recently Published Papers

FAQs

Since when has Immunopharmacology and Immunotoxicology been publishing? Faqs

The Immunopharmacology and Immunotoxicology has been publishing since 1987 till date.

How frequently is the Immunopharmacology and Immunotoxicology published? Faqs

Immunopharmacology and Immunotoxicology is published Quarterly.

Who is the publisher of Immunopharmacology and Immunotoxicology? Faqs

The publisher of Immunopharmacology and Immunotoxicology is TAYLOR & FRANCIS LTD.

Where can I find a journal's aims and scope of Immunopharmacology and Immunotoxicology? Faqs

For the Immunopharmacology and Immunotoxicology's Aims and Scope, please refer to the section above on the page.

How can I view the journal metrics of Immunopharmacology and Immunotoxicology on editage? Faqs

For the Immunopharmacology and Immunotoxicology metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Immunopharmacology and Immunotoxicology? Faqs

The eISSN number is 1532-2513 and pISSN number is 0892-3973 for Immunopharmacology and Immunotoxicology.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Lipopolysaccharide, Flow cytometry, Oxidative stress, Anti-inflammatory, Sepsis, Quercetin, Ulcerative colitis, Experimental autoimmune encephalomyelitis, Prostate cancer, Reactive oxygen species, Gene expression, Osteoarthritis, Glutathione, Fluticasone, Thymic stromal lymphopoietin, Cytokine storm, Nitric oxide, Glycerol, Acute failure, Liver injury.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.